Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

NCHHSTP Newsroom
Your Connection to the Latest HIV/AIDS, Hepatitis, STD and TB News at CDC

2015 International AIDS Society Conference - New CDC Research on HIV PrEP

This week, at the 2015 International AIDS Society Conference in Vancouver, CDC researchers will present important research findings on HIV prevention. The National Institutes of Health announced findings from the ADAPT trial, a clinical study designed to identify the HIV pre-exposure prophylaxis, or PrEP, pill-taking schedules that people are most likely to follow. The study found that young, South African women, as well as men who have sex with men and transgender women in New York and Thailand, can adhere to a daily PrEP regimen. Adherence to the daily regimen was higher than adherence to the two non-daily regimens at all three study sites. CDC conducted the Bangkok arm of the study in collaboration with the Bangkok Metropolitan Administration and the Thailand Ministry of Public Health.

CDC researchers presented findings showing that heterosexual men and women in Botswana enrolled in the 12-month open-label extension of the TDF2 clinical trial were highly adherent to a daily oral combination of tenofovir and emtricitabine (TDF/FTC) for PrEP. Further, sexual risk behavior declined over the course of the study. Finally, a sub-analysis by gender confirms that women who are at risk for HIV are able to adhere to daily PrEP. This is encouraging since some PrEP studies have found that women were not protected from HIV because they did not take the medication regularly, as prescribed.

For your stories about this new research, please find below relevant media materials, as well as other useful background resources.

Primary Materials

Related Materials

CDC awards $216 million to community-based organizations to deliver the most-effective HIV prevention strategies to those in greatest need

Media Inquiries:
HIV/AIDS, Hepatitis, STDs or TB
  • (404) 639-8895
    M-F 9am-5:30pm (ET)
  • Email

All Other Topics

Public Inquiries:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    TTY: (888) 232-6348

  • Contact CDC–INFO

The NCHHSTP Atlas is an interactive tool that provides CDC an effective way to disseminate HIV, Viral Hepatitis, STD and TB data, while allowing users to observe trends and patterns by creating detailed reports, maps, and other graphics. Find out more!

Prevention Through Health Care

May 19. HEPATITIS TESTING DAY.  Click here to learn more.

CDC 24/7 – Saving Lives. Protecting People. Saving Money Through Prevention. Learn More About How CDC Works For You The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #